BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now
Advanced Search

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

19 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Compounds for the treatment of respiratory diseasesBDB
University of Melbourne
RET inhibitors, pharmaceutical compositions and uses thereofBDB
Sunshine Lake Pharma Co.
BCL-2 InhibitorBDB
Beigene
SULFOXIMINE COMPOUND AND USE THEREOFBDB
Medshine Discovery
ISOXAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERED RELATED THERETOBDB
Arena Pharmaceuticals
ALKYL CARBOXYLIC ACID COMPOUNDS AND APPLICATION THEREOFBDB
Medshine Discovery
Compounds for Modulating Epithelial 15-(S)-Lipoxygenase-2 and Methods of Use for SameBDB
University of California
VITAMIN D3-LIKE COMPOUNDBDB
Kanagawa University
Indane derivatives as hypoxia inducible factor-2(α) inhibitorsBDB
Nikang Therapeutics
TREATMENT OF MYELOPROLIFERATIVE DISEASES AND DISORDERS WITH INHIBITORS OF BET FAMILY BDII BROMODOMAINBDB
Poseidon Innovation 1
Quinazoline Derivatives, Pharmaceutical Compositions, and Therapeutic Uses Related to Nox InhibitionBDB
Emory University
Use of 2-substituted indazoles for the treatment and prophylaxis of autoimmune diseasesBDB
Bayer Pharma Aktiengesellschaft
COMPOUND HAVING INHIBITORY ACTIVITY AGAINST O-GLUSACASE AND USE THEREOFBDB
Medifron Dbt
2-oxoimidazolidine-4-carboxamides as NAv1.8 inhibitorsBDB
Merck Sharp & Dohme
INDOLO HEPTAMYL OXIME ANALOG CRYSTAL AS PARP INHIBITOR AND METHOD FOR PREPARING SAMEBDB
Chia Tai Tianqing Pharmaceutical Group
Labelled cannabinergic ligands and related analogsBDB
Individual
Potent and selective inhibitors of monoamine transporters; method of making; and use thereofBDB
The Usa, As Represented By The Secretary, Dhhs
Hetero ring-fused phenyl compounds for inhibiting TNIK and medical uses thereofBDB
Korea Research Institute of Chemical Technology
Cyano-subtituted heterocycles with activity as inhibitors of USP30BDB
Mission Therapeutics